Analyst: The market is in an overly panicked phase, and conditions are not sufficient for BTC to continue a rapid decline
According to Odaily, Greeks.live macro researcher Adam posted on X, stating: "Bitcoin broke through the $70,000 mark without resistance. The next range, starting with 6, is the sideways zone before the Trump rally began, where support remains relatively strong. Options data shows that institutions and large investors are urgently seeking hedges and making bets. The implied volatility of BTC options for the current period has reached 100%, doubling since the beginning of the year. The main monthly options' implied volatility has also surpassed 50%, rising 15% in two weeks, and Skew has hit a new two-year low. The structure of the options market is now completely dominated by bearish sentiment, but there are also some lottery-style deep out-of-the-money bottom-fishing buys emerging. The market is currently in an excessively panicked phase, and the conditions for BTC to continue falling rapidly are not sufficient. A swift clearing of risks in the market is conducive to a rebound in prices."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
